The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Identification of a Vertebrate Sister-Chromatid Separation Inhibitor Involved in Transformation and Tumorigenesis
Abstract
A vertebrate securin (vSecurin) was identified on the basis of its biochemical analogy to the Pds1p protein of budding yeast and the Cut2p protein of fission yeast. The vSecurin protein bound to a vertebrate homolog of yeast separins Esp1p and Cut1p and was degraded by proteolysis mediated by an anaphase-promoting complex in a manner dependent on a destruction motif. Furthermore, expression of a stable Xenopus securin mutant protein blocked sister-chromatid separation but did not block the embryonic cell cycle. The vSecurin proteins share extensive sequence similarity with each other but show no sequence similarity to either of their yeast counterparts. Human securin is identical to the product of the gene called pituitary tumor-transforming gene (PTTG), which is overexpressed in some tumors and exhibits transforming activity in NIH 3T3 cells. The oncogenic nature of increased expression of vSecurin may result from chromosome gain or loss, produced by errors in chromatid separation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antibodies, a laboratory manual
(1989) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(89)90130-3 · Cited by 12,366
Genetic instabilities in human cancers
Lengauer, C., Kinzler, K. W., & Vogelstein, B. (1998) · Nature · doi:10.1038/25292 · Cited by 4,168
Geminin, an Inhibitor of DNA Replication, Is Degraded during Mitosis
McGarry, T. J., & Kirschner, M. W. (1998) · Cell · doi:10.1016/s0092-8674(00)81209-x · Cited by 897
Self-citationCohen-Fix, O., Peters, J. M., Kirschner, M. W., & Koshland, D. (1996) · Genes & Development · doi:10.1101/gad.10.24.3081 · Cited by 778
Self-citationToth, A., Ciosk, R., Uhlmann, F., Galova, M., Schleiffer, A., & Nasmyth, K. (1999) · Genes & Development · doi:10.1101/gad.13.3.320 · Cited by 598
Ciosk, R., Zachariae, W., Michaelis, C., Shevchenko, A., Mann, M., & Nasmyth, K. (1998) · Cell · doi:10.1016/s0092-8674(00)81211-8 · Cited by 593
Isolation and Characterization of a Pituitary Tumor-Transforming Gene (PTTG)
Pei, L. (1997) · Molecular Endocrinology · doi:10.1210/me.11.4.433 · Cited by 576
Anaphase is initiated by proteolysis rather than by the inactivation of maturation-promoting factor
Holloway, S. L., Glotzer, M., King, R. W., & Murray, A. W. (1993) · Cell · doi:10.1016/0092-8674(93)90364-v · Cited by 561
Fang, G., Yu, H., & Kirschner, M. W. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80126-4 · Cited by 486
Self-citationCut2 proteolysis required for sister-chromatid separation in fission yeast
Funabiki, H., Yamano, H., Kumada, K., Nagao, K., Hunt, T., & Yanagida, M. (1996) · Nature · doi:10.1038/381438a0 · Cited by 447
Pituitary Tumor Transforming Gene (PTTG) Expression in Pituitary Adenomas
Zhang, X. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.2.761 · Cited by 440
Tugendreich, S., Tomkiel, J., Earnshaw, W., & Hieter, P. (1995) · Cell · doi:10.1016/0092-8674(95)90336-4 · Cited by 368
Structure, Expression, and Function of Human Pituitary Tumor-Transforming Gene (PTTG)
Zhang, X., Horwitz, G. A., Prezant, T. R., Valentini, A., Nakashima, M., Bronstein, M. D., & Melmed, S. K. (1999) · Molecular Endocrinology · doi:10.1210/me.13.1.156 · Cited by 324
Hirano, T., Funahashi, S.-I., Uemura, T., & Yanagida, M. (1986) · The EMBO Journal · doi:10.1002/j.1460-2075.1986.tb04594.x · Cited by 291
King, R. W., Glotzer, M., & Kirschner, M. W. (1996) · Molecular Biology of the Cell · doi:10.1091/mbc.7.9.1343 · Cited by 281
Self-citationShamu, C., & Murray, A. (1992) · The Journal of cell biology · doi:10.1083/jcb.117.5.921 · Cited by 237
Pds1p is required for faithful execution of anaphase in the yeast, Saccharomyces cerevisiae
Yamamoto, A. (1996) · The Journal of Cell Biology · doi:10.1083/jcb.133.1.85 · Cited by 222
Geminin, a neuralizing molecule that demarcates the future neural plate at the onset of gastrulation
Kroll, K. L., Salic, A. N., Evans, L. M., & Kirschner, M. W. (1998) · Development · doi:10.1242/dev.125.16.3247 · Cited by 217
Self-citationFunabiki, H., Kumada, K., & Yanagida, M. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb01052.x · Cited by 192
Domínguez, Á., Ramos-Morales, F., Romero, F., Rios, R. M., Dreyfus, F., Tortolero, M., & Pintor-Toro, J. A. (1998) · Oncogene · doi:10.1038/sj.onc.1202140 · Cited by 189
Uzawa, S., Samejima, I., Hirano, T., Tanaka, K., & Yanagida, M. (1990) · Cell · doi:10.1016/0092-8674(90)90266-h · Cited by 159
Requirement for ESP1 in the nuclear division of Saccharomyces cerevisiae.
McGrew, J. T., Goetsch, L., Byers, B., & Baum, P. R. (1992) · Molecular Biology of the Cell · doi:10.1091/mbc.3.12.1443 · Cited by 108
Fission yeast Cut2 required for anaphase has two destruction boxes
Funabiki, H., Yamano, H., Nagao, K., Tanaka, H., Yasuda, H., Hunt, T., & Yanagida, M. (1997) · The EMBO Journal · doi:10.1093/emboj/16.19.5977 · Cited by 68
Cited by
A molecular signature of metastasis in primary solid tumors
Ramaswamy, S., Ross, K. N., Lander, E. S., & Golub, T. R. (2003) · Nature Genetics · doi:10.1038/ng1060 · Cited by 2,449
Whitfield, M. L., Sherlock, G., Saldanha, A. J., Murray, J. I., Ball, C. A., Alexander, K. E., Matese, J. C., Perou, C. M., Hurt, M. M., Brown, P. O., et al. (2002) · Molecular Biology of the Cell · doi:10.1091/mbc.02-02-0030 · Cited by 1,527
To cycle or not to cycle: a critical decision in cancer
Malumbres, M., & Barbacid, M. (2001) · Nature Reviews Cancer · doi:10.1038/35106065 · Cited by 1,468
Cleveland, D. W., Mao, Y., & Sullivan, K. F. (2003) · Cell · doi:10.1016/s0092-8674(03)00115-6 · Cited by 1,003
Nasmyth, K. (2001) · Annual Review of Genetics · doi:10.1146/annurev.genet.35.102401.091334 · Cited by 805
Metadata
- Authors
- Zou, H., McGarry, T. J., Bernal, T., & Kirschner, M. W.
- Venue
- Science
- Published
- 1999-07-16
- Volume
- 285
- Issue
- 5426
- Pages
- 418-422
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2038197766
- Cited by
- 805
- References
- 25
- FWCI
- 17.80
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.